Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.
暂无分享,去创建一个
A. Chincarini | B. Boeve | V. Lowe | G. Plazzi | A. Serra | M. Puligheddu | F. Nobili | N. Tachibana | K. Bradley | D. McGowan | F. Pizza | D. Arnaldi | M. Hu | R. Manni | E. Antelmi | K. Šonka | T. Barber | M. Terzaghi | P. Dušek | M. Rolinski | S. Morbelli | M. Bauckneht | Lennon G. Jordan | V. C. De Cock | I. Bossert | M. Miyamoto | T. Miyamoto | M. Figorilli | R. Meli | J. Trnka | T. Miyagawa | D. Zogala | D. Verbizier | Thomas R. Barber | Masayuki Miyamoto
[1] Alan J. Thomas,et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies , 2020, Neurology.
[2] B. Boeve,et al. Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders , 2020, The Journal of Nuclear Medicine.
[3] A. Chincarini,et al. The fate of patients with REM sleep behavior disorder and mild cognitive impairment. , 2020, Sleep medicine.
[4] Yves Dauvilliers,et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study , 2019, Brain : a journal of neurology.
[5] Laura Verga,et al. The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. , 2019, Sleep medicine reviews.
[6] A. Chincarini,et al. Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis. , 2018, Sleep medicine reviews.
[7] H. Berendse,et al. Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies , 2018, NeuroImage: Clinical.
[8] R. Postuma,et al. How does dementia with Lewy bodies start? prodromal cognitive changes in REM sleep behavior disorder , 2017, Annals of neurology.
[9] E. Tolosa,et al. Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder , 2017, Annals of neurology.
[10] Ian A. Watson,et al. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis , 2017, Clinical and translational science.
[11] Alan J. Thomas,et al. Diagnosis and management of dementia with Lewy bodies , 2017, Neurology.
[12] Shengdi Chen,et al. Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases , 2017, Neurology.
[13] H. Shill,et al. Simplified conversion method for unified Parkinson's disease rating scale motor examinations , 2015, Movement disorders : official journal of the Movement Disorder Society.
[14] Günther Deuschl,et al. MDS research criteria for prodromal Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[15] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[16] J. Trojanowski,et al. Conversion between Mini‐Mental State Examination, Montreal Cognitive Assessment, and Dementia Rating Scale‐2 scores in Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.
[17] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[18] H. Vankova. Mini Mental State , 2010 .
[19] Koen Van Laere,et al. EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2 , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[20] F. Nobili,et al. Cognitive‐nigrostriatal relationships in de novo, drug‐naïve Parkinson's disease patients: A [I‐123]FP‐CIT SPECT study , 2010, Movement disorders : official journal of the Movement Disorder Society.
[21] J. Jankovic,et al. Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan , 2007, Movement disorders : official journal of the Movement Disorder Society.
[22] R. M. Costanzo,et al. Cross-cultural comparison of data using the odor stick identification test for Japanese (OSIT-J). , 2006, Chemical senses.
[23] J. Cummings,et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.
[24] Johan Marinus,et al. Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT , 2004, Movement disorders : official journal of the Movement Disorder Society.
[25] I. McKeith,et al. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease , 2004, Neurology.
[26] H. Briner,et al. Smell diskettes as screening test of olfaction. , 1999, Rhinology.
[27] T. Hummel,et al. 'Sniffin' sticks': olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. , 1997, Chemical senses.
[28] R. Doty,et al. Development of the university of pennsylvania smell identification test: A standardized microencapsulated test of olfactory function , 1984, Physiology & Behavior.
[29] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[30] Y. Ben-Shlomo,et al. The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. , 2014, Parkinsonism & related disorders.
[31] J. Ibrahim,et al. Handbook of survival analysis , 2014 .
[32] L. Freedman. Tables of the number of patients required in clinical trials using the logrank test. , 1982, Statistics in medicine.